Literature DB >> 11854219

Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction.

S Magez1, B Stijlemans, G Caljon, H-P Eugster, P De Baetselier.   

Abstract

Trypanosome infections are marked by severe pathological features, including anemia, splenomegaly, and suppression of T-cell proliferation. We have used lymphotoxin-alpha-deficient (LT-alpha(-/-)) mice, as well as LT-alpha-tumor necrosis factor-double-deficient (LT-alpha(-/-) TNF(-/-)) mice, to analyze the contributions of these related cytokines in both induction of trypanosomosis-associated immunopathology and infection control. Moreover, as the cytokine-deficient mice used have no detectable lymph nodes and lack germinal-center formation upon immune stimulation, we have analyzed the functional importance of both the lymph nodes and spleen during experimental Trypanosoma brucei infections. First, we show that the absence of LT-alpha does not significantly alter early trypanosomosis development or pathology but does result in better control of late-stage parasitemia levels and slightly prolonged survival. This increased survival of infected LT-alpha(-/-) mice coincides with the appearance of increased chronic-stage anti-trypanosome immunoglobulin M (IgM)-IgG2a serum titers that are generated in the absence of functional peripheral lymphoid tissue and do not require germinal-center formation. Second, we show that splenectomized mice control their parasitemia to the same extent as fully immune-competent littermates. Finally, using LT-alpha(-/-) TNF(-/-) double-deficient mice, we show that in these mice T. brucei infections are very well controlled during the chronic infection stage and that infection-induced pathology is minimized. Together, these findings indicate that while increased IgM-IgG2a anti-trypanosome antibody titers (generated in the absence of LT-alpha, peripheral lymph nodes, and germinal-center formation) coincide with improved parasitemia control, it is TNF that has a major impact on trypanosomosis-associated immunopathology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854219      PMCID: PMC127790          DOI: 10.1128/IAI.70.3.1342-1351.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Two TNF receptors.

Authors:  L A Tartaglia; D V Goeddel
Journal:  Immunol Today       Date:  1992-05

Review 2.  Biology of African trypanosomes in the tsetse fly.

Authors:  K Vickerman; L Tetley; K A Hendry; C M Turner
Journal:  Biol Cell       Date:  1988       Impact factor: 4.458

3.  Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice.

Authors:  C A Hunter; J W Gow; P G Kennedy; F W Jennings; M Murray
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Mapping the lectin-like activity of tumor necrosis factor.

Authors:  R Lucas; S Magez; R De Leys; L Fransen; J P Scheerlinck; M Rampelberg; E Sablon; P De Baetselier
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

5.  Cytoskeleton-associated antigens from African trypanosomes are recognized by self-reactive antibodies of uninfected mice.

Authors:  N Müller; M Imboden; E Detmer; J M Mansfield; T Seebeck
Journal:  Parasitology       Date:  1993-11       Impact factor: 3.234

6.  Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins.

Authors:  K W Schleifer; J M Mansfield
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

7.  Bidirectional activating signals between Trypanosoma brucei and CD8+ T cells: a trypanosome-released factor triggers interferon-gamma production that stimulates parasite growth.

Authors:  T Olsson; M Bakhiet; C Edlund; B Höjeberg; P H Van der Meide; K Kristensson
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

8.  Inhibition of T-cell responsiveness during experimental infections with Trypanosoma brucei: active involvement of endogenous gamma interferon.

Authors:  A Darji; M Sileghem; H Heremans; L Brys; P De Baetselier
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

9.  Tumour necrosis factor production by monocytes from cattle infected with Trypanosoma (Duttonella) vivax and Trypanosoma (Nannomonas) congolense: possible association with severity of anaemia associated with the disease.

Authors:  M Sileghem; J N Flynn; L Logan-Henfrey; J Ellis
Journal:  Parasite Immunol       Date:  1994-01       Impact factor: 2.280

10.  Genetics of resistance to the African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses.

Authors:  A L De Gee; R F Levine; J M Mansfield
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

View more
  11 in total

Review 1.  Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.

Authors:  Thomas W Spahn; Hans-Pietro Eugster; Adriano Fontana; Wolfram Domschke; Torsten Kucharzik
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

2.  Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response.

Authors:  Guy Caljon; Jan Van Den Abbeele; Benoît Stijlemans; Marc Coosemans; Patrick De Baetselier; Stefan Magez
Journal:  Infect Immun       Date:  2006-09-05       Impact factor: 3.441

3.  Clinical chemistry of congenic mice with quantitative trait loci for predicted responses to Trypanosoma congolense infection.

Authors:  Birgit Rathkolb; Harry A Noyes; Andy Brass; Paul Dark; Helmut Fuchs; Valérie Gailus-Durner; John Gibson; Martin Hrabé de Angelis; Moses Ogugo; Fuad Iraqi; Steve J Kemp; Jan Naessens; Mathew E Pope; Eckhard Wolf; Morris Agaba
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

4.  Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.

Authors:  Christian R Engwerda; Manabu Ato; Simona Stäger; Clare E Alexander; Amanda C Stanley; Paul M Kaye
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 5.  Role of cytokines in Trypanosoma brucei-induced anaemia: A review of the literature.

Authors:  J Musaya; E Matovu; M Nyirenda; J Chisi
Journal:  Malawi Med J       Date:  2015-06       Impact factor: 0.875

Review 6.  African Trypanosomiasis-Associated Anemia: The Contribution of the Interplay between Parasites and the Mononuclear Phagocyte System.

Authors:  Benoit Stijlemans; Patrick De Baetselier; Stefan Magez; Jo A Van Ginderachter; Carl De Trez
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

7.  Influence of the Draining Lymph Nodes and Organized Lymphoid Tissue Microarchitecture on Susceptibility to Intradermal Trypanosoma brucei Infection.

Authors:  Omar A Alfituri; Barry M Bradford; Edith Paxton; Liam J Morrison; Neil A Mabbott
Journal:  Front Immunol       Date:  2020-06-03       Impact factor: 7.561

Review 8.  Salivarian Trypanosomosis: A Review of Parasites Involved, Their Global Distribution and Their Interaction With the Innate and Adaptive Mammalian Host Immune System.

Authors:  Magdalena Radwanska; Nick Vereecke; Violette Deleeuw; Joar Pinto; Stefan Magez
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

9.  Mouse experiments demonstrate differential pathogenicity and virulence of Trypanosoma brucei rhodesiense strains.

Authors:  Limo William Kipkorir; Thuita Kibuthu John; Orindi Benedict Owino; Oidho John; Shivairo Robert; Masiga Daniel; Adung'a Vincent Owino
Journal:  Exp Parasitol       Date:  2021-07-17       Impact factor: 2.132

10.  Confining Trypanosoma brucei in emulsion droplets reveals population variabilities in division rates and improves in vitro cultivation.

Authors:  Simone H Oldenburg; Lionel Buisson; Thomas Beneyton; Deniz Pekin; Magali Thonnus; Frédéric Bringaud; Loïc Rivière; Jean-Christophe Baret
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.